Solve your dosage form and delivery challenges with Lonza Capsule Application Lab
Supported by:
21 February 2024
Shares
- Like
- Digg
- Del
- Tumblr
- VKontakte
- Buffer
- Love This
- Odnoklassniki
- Meneame
- Blogger
- Amazon
- Yahoo Mail
- Gmail
- AOL
- Newsvine
- HackerNews
- Evernote
- MySpace
- Mail.ru
- Viadeo
- Line
- Comments
- Yummly
- SMS
- Viber
- Telegram
- Subscribe
- Skype
- Facebook Messenger
- Kakao
- LiveJournal
- Yammer
- Edgar
- Fintel
- Mix
- Instapaper
- Copy Link
Pharmaceutical companies are under constant pressure to create improved, lower risk and cost-effective drugs faster. The Lonza Capsule Application Lab services can augment your existing research and development to meet stringent requirements.
Register to watch this webinar for free!
Join this webinar to hear from industry expert Vincent Jannin as he shares more about how to overcome your technical obstacles and explores the future of dosage form and delivery.
Each stage of the drug development process is beset with continually increasing challenges and risks.
The high-risk stage of drug development can be mitigated by utilising dosage forms developed to reduce the probability of failure. As time to market is becoming critical, turnaround times for new formulations can be improved by collaborating with industry experts. The approximate cost – $2.3 billion* – to develop and produce a new drug, can be reduced by optimising the manufacturing process.
The Lonza Capsule Application Lab typically supports three categories of projects: formulation development, capsule customisation and process development.
Formulation: The Capsule Application Lab can formulate active pharmaceutical ingredients (API) with either standard formulations or enabling technologies, develop new capsules and implement new processes, such as granulation.
Capsule customisation: The Capsule Application Lab can develop capsules of various sizes, designs and with various polymers.
Process development: The team at Lonza can set encapsulation process parameters both for liquid filling and powder filling and produce technical batches that can be used for early stability testing or evaluation.
Register your details now to secure your seat.
Vincent Jannin, Director, R&D Head of Capsule Application Lab, Lonza Capsules and Health Ingredient Dr. Vincent Jannin is Head of Capsule Applications Services at Lonza CHI. Previously, he held diverse positions up to Research Director at Gattefossé, and was a lecturer at Lyon University. Vincent earned his PharmD and PhD in Pharmaceutical Technology from the University of Bourgogne, and received his habilitation (HDR) from the University of Lyon. Vincent has published more than 140 peer-reviewed papers, and given more than 60 lectures on Drug Delivery Systems. Is the webinar free? Yes – there is no charge to watch the webinar, either live or on-demand. When will the webinar take place? 21 February 2024 at 2.00pm GMT. Can I watch it later? The webinar will become available to watch on-demand shortly after the live webinar takes place. What are the benefits of attending live? You’ll be able to ask the speakers your questions, which will be answered live in the Q&A towards the end of the session. How long will the webinar be? This webinar will last up to an hour. What do I need to watch this webinar? All you need is a computer with an internet connection. We recommend using headphones if possible if you’re in an office environment.KEY TAKEAWAYS
OUR SPEAKER
FAQs
FAQs
